<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03674515</url>
  </required_header>
  <id_info>
    <org_study_id>BOUGE CANCER (29BRC17.0038)</org_study_id>
    <nct_id>NCT03674515</nct_id>
  </id_info>
  <brief_title>Study of Program Interest &quot;Bouge&quot; to Improve the Daily Physical Activity in Processings Treatment of Non-metastatic Breast Cancer</brief_title>
  <acronym>BOUGE CANCER</acronym>
  <official_title>Study of Program Interest &quot;Bouge&quot; to Improve the Daily Physical Activity and Tolerance in Processings Treatment of Non-metastatic Breast Cancer at the Beginning Weekly Taxol Adjuvant Chemotherapy (Www.Bouge-coaching.Com)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the &quot;Bouge&quot; digital program (smartphone application) to increase the daily physical
      activity of breast cancer patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Controlled, randomized, open, prospective, multicentric study, 214 volunteer patients aged
      between 18 and 70, with breast cancer, at the start of TAXOL treatment, possessing a
      smartphone, will be recruited and randomized into two groups:

      107 in the control group (smartphone application &quot;placebo&quot; = number of steps) 107 will be
      equipped with the application &quot;Bouge&quot; = coached group

      For three months, the patients do their daily physical activity. The &quot;coached&quot; group, through
      the smartphone application &quot;Bouge&quot;, receives computer coaching to increase their physical
      activity (no direct medical intervention, only notifications and computer pusch).

      The control group is not coached by the application (simple display of the number of step)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 15, 2017</start_date>
  <completion_date type="Anticipated">March 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 12, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Increased daily physical activity (number of steps) using the smartphone application &quot;BOUGE&quot;</measure>
    <time_frame>12 weeks</time_frame>
    <description>The objective is an increase of 3000 steps daily between J 1 and J 90 (an increase of 15 000 steps between S1 and S 12)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Well-being,</measure>
    <time_frame>12 weeks</time_frame>
    <description>Scale EQ-5D-5L,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Well-being,</measure>
    <time_frame>12 weeks</time_frame>
    <description>Scale EORTC QLQ-C30,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>12 weeks</time_frame>
    <description>Scale WHO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep</measure>
    <time_frame>12 weeks</time_frame>
    <description>Scale SPIEGEL</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">214</enrollment>
  <condition>Physical Activity</condition>
  <condition>Breast Cancer</condition>
  <condition>Mobile Health Apps</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Smartphone application &quot;placebo&quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>&quot;Bouge&quot;</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Smartphone equipped with the application &quot;Bouge&quot;</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Smartphone application &quot;placebo&quot;</intervention_name>
    <description>Strategy based on smartphone application &quot;placebo&quot;</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Smartphone equipped with application &quot;bouge&quot; = Coach group</intervention_name>
    <description>Strategy based on smartphone application &quot;bouge&quot;</description>
    <arm_group_label>&quot;Bouge&quot;</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        non-metastatic breast cancer start of treatment with TAXOL compatible smartphone

        Exclusion Criteria:

        age metastatic breast cancer
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yannick GUILLODO</last_name>
    <phone>02.98.34.72.64</phone>
    <email>yannick.guillodo@chu-brest.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène SIMON</last_name>
      <email>helene.simon@chu-brest.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Morlaix</name>
      <address>
        <city>Morlaix</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthieu MULLER</last_name>
      <email>m.muller@ch-morlaix.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>February 19, 2018</study_first_submitted>
  <study_first_submitted_qc>September 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2018</study_first_posted>
  <last_update_submitted>September 14, 2018</last_update_submitted>
  <last_update_submitted_qc>September 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

